Elia Casirati

Publication Activity (10 Years)

Years Active: 2021-2024
Publications (10 Years): 7

Top Topics

Cervical Cancer Screening

Endoplasmic Reticulum

Top Venues

Clinical and translational medicine

Nature medicine

Expert opinion on therapeutic targets

This page only lists publications with an associated author ORCID identifier.

Publications

Alessandro Cherubini, Elia Casirati, Serena Pelusi, Luca Vittorio Valenti
Estrogen-ER-α axis induces PNPLA3 p.I148M protein variant to promote steatotic liver disease susceptibility in women. Clinical and translational medicine 14 (1) (2024)
Alessandro Cherubini, Mahnoosh Ostadreza, Oveis Jamialahmadi, Serena Pelusi, Eniada Rrapaj, Elia Casirati, Giulia Passignani, Marjan Norouziesfahani, Elena Sinopoli, Guido A Baselli, Clara Meda, Paola Dongiovanni, Daniele Dondossola, Neil Youngson, Aikaterini Tourna, Shilpa Chokshi, Elisabetta Bugianesi, null null, Sara Della Torre, Daniele Prati, Stefano Romeo, Luca Vittorio Valenti
Author Correction: Interaction between estrogen receptor-α and PNPLA3 p.I148M variant drives fatty liver disease susceptibility in women. Nature medicine (2024)
Alessandro Cherubini, Elia Casirati, Serena Pelusi, Luca Vittorio Valenti
Estrogen-ER-α axis induces PNPLA3 p.I148M protein variant to promote steatotic liver disease susceptibility in women. Clinical and translational medicine 14 (1) (2024)
Alessandro Cherubini, Elia Casirati, Serena Pelusi, Luca Vittorio Valenti
Estrogen-ER-α axis induces PNPLA3 p.I148M protein variant to promote steatotic liver disease susceptibility in women. Clinical and translational medicine 14 (1) (2024)
Alessandro Cherubini, Elia Casirati, Serena Pelusi, Luca Vittorio Valenti
Estrogen-ER-α axis induces PNPLA3 p.I148M protein variant to promote steatotic liver disease susceptibility in women. Clinical and translational medicine 14 (1) (2024)
Alessandro Cherubini, Mahnoosh Ostadreza, Oveis Jamialahmadi, Serena Pelusi, Eniada Rrapaj, Elia Casirati, Giulia Passignani, Marjan Norouziesfahani, Elena Sinopoli, Guido A Baselli, Clara Meda, Paola Dongiovanni, Daniele Dondossola, Neil Youngson, Aikaterini Tourna, Shilpa Chokshi, Elisabetta Bugianesi, null null, Sara Della Torre, Daniele Prati, Stefano Romeo, Luca Vittorio Valenti
Interaction between estrogen receptor-α and PNPLA3 p.I148M variant drives fatty liver disease susceptibility in women. Nature medicine (2023)
Alessandro Cherubini, Elia Casirati, Melissa Tomasi, Luca Vittorio Valenti
PNPLA3 as a therapeutic target for fatty liver disease: the evidence to date. Expert opinion on therapeutic targets 25 (12) (2021)